Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-10-09

Clinical Trial Update: Tecovirimat for Treatment of Monkeypox Virus [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating tecovirimat for the treatment of monkeypox has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tecovirimat (tecovirimat)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Monkeypox | Phase 2 | Status: COMPLETED | Results posted: 2025-10-09